Enhancement of Dendritic Cell Production by Fms-Like Tyrosine Kinase-3 Ligand Increases the Resistance of Mice to a Burn Wound Infection
Fms-like tyrosine kinase-3 ligand (Flt3L) is a hemopoietic cytokine that stimulates the production of dendritic cells. This study evaluated the ability of Flt3L-enhanced dendritic cell production to increase the resistance of mice to a burn wound infection with Pseudomonas aeruginosa, a common sourc...
Saved in:
Published in | The Journal of immunology (1950) Vol. 174; no. 1; pp. 404 - 410 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Am Assoc Immnol
01.01.2005
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Fms-like tyrosine kinase-3 ligand (Flt3L) is a hemopoietic cytokine that stimulates the production of dendritic cells. This study evaluated the ability of Flt3L-enhanced dendritic cell production to increase the resistance of mice to a burn wound infection with Pseudomonas aeruginosa, a common source of infections in burn patients that have impaired immunity and are susceptible to opportunistic microorganisms. Treatment of mice with Flt3L for 5 days caused a significant increase in dendritic cell numbers in the spleen and significantly increased survival upon a subsequent burn wound infection. Improved survival in Flt3L-treated mice was associated with limited bacterial growth and spread within the burn wounds and a decrease in systemic dissemination of P. aeruginosa. Resistance to burn wound infection could also be conferred to recipient mice by the adoptive transfer of dendritic cells that had been isolated from spleens of Flt3L-treated mice. Adoptive transfer of the same number of splenic dendritic cells from nontreated mice did not confer resistance to burn wound infection. These data indicate that Flt3L can increase the resistance of mice to a P. aeruginosa burn wound infection through both stimulation of dendritic cell production and enhancement of dendritic cell function. |
---|---|
AbstractList | Fms-like tyrosine kinase-3 ligand (Flt3L) is a hemopoietic cytokine that stimulates the production of dendritic cells. This study evaluated the ability of Flt3L-enhanced dendritic cell production to increase the resistance of mice to a burn wound infection with Pseudomonas aeruginosa, a common source of infections in burn patients that have impaired immunity and are susceptible to opportunistic microorganisms. Treatment of mice with Flt3L for 5 days caused a significant increase in dendritic cell numbers in the spleen and significantly increased survival upon a subsequent burn wound infection. Improved survival in Flt3L-treated mice was associated with limited bacterial growth and spread within the burn wounds and a decrease in systemic dissemination of P. aeruginosa. Resistance to burn wound infection could also be conferred to recipient mice by the adoptive transfer of dendritic cells that had been isolated from spleens of Flt3L-treated mice. Adoptive transfer of the same number of splenic dendritic cells from nontreated mice did not confer resistance to burn wound infection. These data indicate that Flt3L can increase the resistance of mice to a P. aeruginosa burn wound infection through both stimulation of dendritic cell production and enhancement of dendritic cell function. Abstract Fms-like tyrosine kinase-3 ligand (Flt3L) is a hemopoietic cytokine that stimulates the production of dendritic cells. This study evaluated the ability of Flt3L-enhanced dendritic cell production to increase the resistance of mice to a burn wound infection with Pseudomonas aeruginosa, a common source of infections in burn patients that have impaired immunity and are susceptible to opportunistic microorganisms. Treatment of mice with Flt3L for 5 days caused a significant increase in dendritic cell numbers in the spleen and significantly increased survival upon a subsequent burn wound infection. Improved survival in Flt3L-treated mice was associated with limited bacterial growth and spread within the burn wounds and a decrease in systemic dissemination of P. aeruginosa. Resistance to burn wound infection could also be conferred to recipient mice by the adoptive transfer of dendritic cells that had been isolated from spleens of Flt3L-treated mice. Adoptive transfer of the same number of splenic dendritic cells from nontreated mice did not confer resistance to burn wound infection. These data indicate that Flt3L can increase the resistance of mice to a P. aeruginosa burn wound infection through both stimulation of dendritic cell production and enhancement of dendritic cell function. |
Author | Lin, Chengyie Cui, Weihua Toliver-Kinsky, Tracy E Murphey, Erle D Sherwood, Edward R |
Author_xml | – sequence: 1 fullname: Toliver-Kinsky, Tracy E – sequence: 2 fullname: Cui, Weihua – sequence: 3 fullname: Murphey, Erle D – sequence: 4 fullname: Lin, Chengyie – sequence: 5 fullname: Sherwood, Edward R |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/15611264$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkc1OGzEUhS0EKgH6Aiwqr7qb4J-xnSzblD8RBEJUXVoezx1iOmODPaMob9DHxgNBWXZ1pKNzPsv3HKF9HzwgdErJtCTl_OzZdd3gQzulqpzS0dtDEyoEKaQkch9NCGGsoEqqQ3SU0jMhRBJWfkGHVEhKmSwn6N-5XxlvoQPf49DgX-Dr6Hpn8QLaFt_HUA-2d8HjaoMvulQs3V_Aj5sYkvOAb5w3CQqOl-7J-BpfexshOwn3K8APkFzqR_yIvnVZ-4AN_jlEj_-E4b3QwDv_BB00pk3wdavH6PfF-ePiqljeXV4vfiwLKxjrCzu3RlnLZlktIaBoTWsDnBnFm8oyYkBWFRVzMxNzMQPF6pmUqqk4V8xaw4_R9w_uSwyvA6Redy7Z_FfjIQxJS8U5U6X4b5AqJRTlMgfZR9Dmo6QIjX6JrjNxoynR41D6c6jcKTUdvVz6tqUPVQf1rrJdZvf8yj2t1i6CTp1p2xyner1e70hv_nGhXw |
CitedBy_id | crossref_primary_10_1097_SHK_0000000000000964 crossref_primary_10_1517_14712598_7_7_929 crossref_primary_10_1016_j_legalmed_2014_01_008 crossref_primary_10_1007_s00540_014_1882_y crossref_primary_10_3109_13693786_2010_509744 crossref_primary_10_1128_IAI_01299_10 crossref_primary_10_1016_j_cellimm_2011_06_020 crossref_primary_10_1016_j_cpem_2014_04_002 crossref_primary_10_1016_j_intimp_2023_110738 crossref_primary_10_3389_fimmu_2023_1113948 crossref_primary_10_1097_SHK_0b013e31819e2937 crossref_primary_10_1007_s10753_013_9753_5 crossref_primary_10_1007_s10753_009_9156_9 crossref_primary_10_1152_ajplung_00408_2006 crossref_primary_10_1016_j_jss_2013_09_042 crossref_primary_10_1152_ajpcell_00337_2019 crossref_primary_10_1371_journal_pone_0159624 crossref_primary_10_1016_j_cpsurg_2020_100779 crossref_primary_10_1186_s12986_021_00592_x crossref_primary_10_1189_jlb_0212072 crossref_primary_10_1038_nri3552 crossref_primary_10_1097_SHK_0b013e31815abe80 crossref_primary_10_1097_XCS_0000000000000119 crossref_primary_10_1111_j_1365_2249_2012_04641_x crossref_primary_10_1111_imm_13320 crossref_primary_10_1371_journal_pone_0148452 crossref_primary_10_4049_jimmunol_181_12_8513 crossref_primary_10_3390_ijms23052444 crossref_primary_10_1016_j_ajpath_2012_06_039 crossref_primary_10_1016_j_intimp_2018_03_002 crossref_primary_10_1371_journal_ppat_1007360 crossref_primary_10_1021_acsami_6b00291 crossref_primary_10_1038_s41598_017_16869_2 crossref_primary_10_1097_01_shk_0000238069_84826_1b crossref_primary_10_1155_2015_903720 crossref_primary_10_1016_j_immuni_2021_02_004 crossref_primary_10_1002_bab_1027 crossref_primary_10_1189_jlb_1A0815_377R crossref_primary_10_1097_CCM_0000000000000879 crossref_primary_10_1189_jlb_0408257 crossref_primary_10_1097_SHK_0b013e3181ce2be8 crossref_primary_10_1016_j_coph_2014_07_013 crossref_primary_10_1097_01_BCR_0000238083_95170_2A crossref_primary_10_2119_molmed_2009_00048 crossref_primary_10_1097_SHK_0b013e31829aef41 crossref_primary_10_14336_AD_2020_0627 crossref_primary_10_1016_j_molimm_2018_07_007 crossref_primary_10_1113_JP274841 crossref_primary_10_1111_imm_12423 crossref_primary_10_2119_2007_00102_Monneret crossref_primary_10_1093_jbcr_irz007 crossref_primary_10_1186_s12865_016_0188_2 crossref_primary_10_1016_j_vaccine_2008_06_044 crossref_primary_10_4049_jimmunol_0903619 crossref_primary_10_4049_jimmunol_180_5_3038 crossref_primary_10_1111_nyas_14333 crossref_primary_10_1186_1471_2172_10_47 crossref_primary_10_1016_j_cyto_2008_10_005 crossref_primary_10_1016_j_legalmed_2013_10_002 crossref_primary_10_1111_wrr_12388 crossref_primary_10_1016_j_ccm_2008_06_010 crossref_primary_10_1007_s00018_009_0251_8 crossref_primary_10_4049_jimmunol_1601463 crossref_primary_10_1016_j_medin_2009_11_005 crossref_primary_10_1007_s11481_018_9819_0 crossref_primary_10_1038_s41598_018_21282_4 crossref_primary_10_1189_jlb_4A0815_362R crossref_primary_10_1097_BCR_0b013e318171122c |
Cites_doi | 10.4049/jimmunol.171.8.3983 10.1097/00005373-199803000-00008 10.1016/S1567-5769(01)00122-9 10.1016/S0301-472X(01)00722-6 10.1002/(SICI)1097-0320(20000501)40:1<50::AID-CYTO7>3.0.CO;2-P 10.1128/IAI.71.6.3058-3067.2003 10.1097/00006454-200010000-00010 10.1007/BF00952962 10.1177/000313480006600220 10.1084/jem.20030323 10.1002/jlb.61.5.575 10.1097/00006534-200204010-00020 10.1097/00004630-199211000-00002 10.1084/jem.188.11.2075 10.4049/jimmunol.171.1.325 10.1084/jem.20021900 10.1242/jeb.200.14.2057 10.1128/iai.44.3.554-558.1984 10.4049/jimmunol.171.2.909 10.1002/eji.200324336 10.1517/14656566.4.3.369 10.4049/jimmunol.170.10.5075 10.1001/archsurg.134.12.1317 10.1002/eji.200324443 10.1097/00005373-199512000-00023 10.1182/blood.V96.3.878.015k15_878_884 10.1001/archsurg.133.7.715 10.1097/00000658-199522240-00006 10.1084/jem.176.4.1215 10.4049/jimmunol.161.6.2817 10.1084/jem.189.12.1981 10.4049/jimmunol.172.7.4077 10.1128/IAI.67.11.5854-5862.1999 10.1046/j.1365-2567.2001.01180.x 10.1016/S0305-4179(01)00070-5 10.1038/7403 10.1002/eji.1830260603 10.1097/00024382-200014030-00005 10.1164/rccm.200208-950OC 10.4049/jimmunol.167.3.1179 10.1097/00004630-199511000-00003 10.1182/blood.V95.11.3489.011k45_3489_3497 10.1002/bjs.1800820618 10.1128/IAI.69.2.673-680.2001 10.1097/00024382-200210000-00006 10.1515/CCLM.1999.036 10.1097/00005373-198902000-00007 10.1182/blood.V97.11.3333 10.4049/jimmunol.168.5.2493 10.1016/S0165-2478(03)00151-2 10.4049/jimmunol.170.12.6355 10.1001/archsurg.1991.01410250080013 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7T5 H94 7X8 |
DOI | 10.4049/jimmunol.174.1.404 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Immunology Abstracts AIDS and Cancer Research Abstracts MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef AIDS and Cancer Research Abstracts Immunology Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE AIDS and Cancer Research Abstracts CrossRef MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1550-6606 |
EndPage | 410 |
ExternalDocumentID | 10_4049_jimmunol_174_1_404 15611264 www174_1_404 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | - 08R 2WC 34G 39C 3O- 53G 55 5GY 5RE 5VS 79B 85S 8RP AALRV AARDX ABEFU ABFLS ABOCM ABPPZ ABPTK ACGFS ACIWK ACNCT ACPRK ADACO ADBBV ADKFC AENEX AETEA AFFNX AFRAH AJYGW ALMA_UNASSIGNED_HOLDINGS BAWUL D0L DIK DU5 E3Z EBS EJD F5P FH7 FRP G8K GJ GX1 H13 IH2 J5H K-O K78 KQ8 L7B MVM MYA NEJ O0- OK1 P0W P2P PQEST PQQKQ R.V RHF RHI RZQ SJN TWZ VH1 WH7 WOQ X X7M XJT ZA5 ZE2 ZGI --- -~X .55 .GJ 18M ABCQX ABJNI ACGFO ADNWM AFHIN AFOSN AHWXS AI. AIZAD BTFSW CGR CUY CVF ECM EIF NPM TR2 W8F XSW XTH YHG AAYXX CITATION 7T5 H94 7X8 ABDPE |
ID | FETCH-LOGICAL-c522t-c9ca7cc289cac00e71d1dae32a73fbc20ae6bb159a85958e72d8667fb3372cca3 |
ISSN | 0022-1767 |
IngestDate | Sat Oct 26 00:47:16 EDT 2024 Fri Oct 25 07:04:44 EDT 2024 Thu Sep 26 18:30:21 EDT 2024 Sat Sep 28 08:38:37 EDT 2024 Tue Nov 10 19:21:06 EST 2020 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c522t-c9ca7cc289cac00e71d1dae32a73fbc20ae6bb159a85958e72d8667fb3372cca3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
OpenAccessLink | https://journals.aai.org/jimmunol/article-pdf/174/1/404/1192509/404.pdf |
PMID | 15611264 |
PQID | 17757136 |
PQPubID | 23462 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_67332745 proquest_miscellaneous_17757136 crossref_primary_10_4049_jimmunol_174_1_404 pubmed_primary_15611264 highwire_smallpub1_www174_1_404 |
ProviderPackageCode | RHF RHI |
PublicationCentury | 2000 |
PublicationDate | 20050101 2005-Jan-01 2005-01-01 |
PublicationDateYYYYMMDD | 2005-01-01 |
PublicationDate_xml | – month: 01 year: 2005 text: 20050101 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | The Journal of immunology (1950) |
PublicationTitleAlternate | J Immunol |
PublicationYear | 2005 |
Publisher | Am Assoc Immnol |
Publisher_xml | – name: Am Assoc Immnol |
References | 2023010119261719100_R34 2023010119261719100_R35 2023010119261719100_R32 2023010119261719100_R33 2023010119261719100_R38 2023010119261719100_R39 2023010119261719100_R36 2023010119261719100_R37 2023010119261719100_R30 2023010119261719100_R31 2023010119261719100_R45 2023010119261719100_R46 2023010119261719100_R43 2023010119261719100_R44 2023010119261719100_R49 2023010119261719100_R47 2023010119261719100_R48 2023010119261719100_R41 2023010119261719100_R42 2023010119261719100_R40 2023010119261719100_R12 2023010119261719100_R56 2023010119261719100_R13 2023010119261719100_R10 2023010119261719100_R54 2023010119261719100_R11 2023010119261719100_R55 2023010119261719100_R16 2023010119261719100_R17 2023010119261719100_R14 2023010119261719100_R15 2023010119261719100_R52 2023010119261719100_R53 2023010119261719100_R50 2023010119261719100_R51 2023010119261719100_R18 2023010119261719100_R19 2023010119261719100_R23 2023010119261719100_R24 2023010119261719100_R21 2023010119261719100_R22 2023010119261719100_R27 2023010119261719100_R28 2023010119261719100_R25 2023010119261719100_R26 2023010119261719100_R9 2023010119261719100_R20 2023010119261719100_R2 2023010119261719100_R1 2023010119261719100_R4 2023010119261719100_R3 2023010119261719100_R6 2023010119261719100_R5 2023010119261719100_R8 2023010119261719100_R7 2023010119261719100_R29 |
References_xml | – ident: 2023010119261719100_R27 doi: 10.4049/jimmunol.171.8.3983 – ident: 2023010119261719100_R26 doi: 10.1097/00005373-199803000-00008 – ident: 2023010119261719100_R48 doi: 10.1016/S1567-5769(01)00122-9 – ident: 2023010119261719100_R49 doi: 10.1016/S0301-472X(01)00722-6 – ident: 2023010119261719100_R31 doi: 10.1002/(SICI)1097-0320(20000501)40:1<50::AID-CYTO7>3.0.CO;2-P – ident: 2023010119261719100_R22 doi: 10.1128/IAI.71.6.3058-3067.2003 – ident: 2023010119261719100_R1 doi: 10.1097/00006454-200010000-00010 – ident: 2023010119261719100_R36 doi: 10.1007/BF00952962 – ident: 2023010119261719100_R28 doi: 10.1177/000313480006600220 – ident: 2023010119261719100_R20 doi: 10.1084/jem.20030323 – ident: 2023010119261719100_R8 doi: 10.1002/jlb.61.5.575 – ident: 2023010119261719100_R25 doi: 10.1097/00006534-200204010-00020 – ident: 2023010119261719100_R9 doi: 10.1097/00004630-199211000-00002 – ident: 2023010119261719100_R50 doi: 10.1084/jem.188.11.2075 – ident: 2023010119261719100_R4 – ident: 2023010119261719100_R51 doi: 10.4049/jimmunol.171.1.325 – ident: 2023010119261719100_R40 doi: 10.1084/jem.20021900 – ident: 2023010119261719100_R33 doi: 10.1242/jeb.200.14.2057 – ident: 2023010119261719100_R5 doi: 10.1128/iai.44.3.554-558.1984 – ident: 2023010119261719100_R56 doi: 10.4049/jimmunol.171.2.909 – ident: 2023010119261719100_R35 doi: 10.1002/eji.200324336 – ident: 2023010119261719100_R16 doi: 10.1517/14656566.4.3.369 – ident: 2023010119261719100_R43 doi: 10.4049/jimmunol.170.10.5075 – ident: 2023010119261719100_R10 – ident: 2023010119261719100_R13 doi: 10.1001/archsurg.134.12.1317 – ident: 2023010119261719100_R39 doi: 10.1002/eji.200324443 – ident: 2023010119261719100_R17 doi: 10.1097/00005373-199512000-00023 – ident: 2023010119261719100_R24 doi: 10.1182/blood.V96.3.878.015k15_878_884 – ident: 2023010119261719100_R30 doi: 10.1001/archsurg.133.7.715 – ident: 2023010119261719100_R6 doi: 10.1097/00000658-199522240-00006 – ident: 2023010119261719100_R46 doi: 10.1084/jem.176.4.1215 – ident: 2023010119261719100_R23 doi: 10.4049/jimmunol.161.6.2817 – ident: 2023010119261719100_R45 doi: 10.1084/jem.189.12.1981 – ident: 2023010119261719100_R38 doi: 10.4049/jimmunol.172.7.4077 – ident: 2023010119261719100_R29 doi: 10.1128/IAI.67.11.5854-5862.1999 – ident: 2023010119261719100_R52 doi: 10.1046/j.1365-2567.2001.01180.x – ident: 2023010119261719100_R2 doi: 10.1016/S0305-4179(01)00070-5 – ident: 2023010119261719100_R32 – ident: 2023010119261719100_R42 doi: 10.1038/7403 – ident: 2023010119261719100_R47 doi: 10.1002/eji.1830260603 – ident: 2023010119261719100_R11 doi: 10.1097/00024382-200014030-00005 – ident: 2023010119261719100_R34 doi: 10.1164/rccm.200208-950OC – ident: 2023010119261719100_R44 doi: 10.4049/jimmunol.167.3.1179 – ident: 2023010119261719100_R3 doi: 10.1097/00004630-199511000-00003 – ident: 2023010119261719100_R21 doi: 10.1182/blood.V95.11.3489.011k45_3489_3497 – ident: 2023010119261719100_R18 doi: 10.1002/bjs.1800820618 – ident: 2023010119261719100_R53 doi: 10.1128/IAI.69.2.673-680.2001 – ident: 2023010119261719100_R15 doi: 10.1097/00024382-200210000-00006 – ident: 2023010119261719100_R12 – ident: 2023010119261719100_R14 doi: 10.1515/CCLM.1999.036 – ident: 2023010119261719100_R7 doi: 10.1097/00005373-198902000-00007 – ident: 2023010119261719100_R37 doi: 10.1182/blood.V97.11.3333 – ident: 2023010119261719100_R55 doi: 10.4049/jimmunol.168.5.2493 – ident: 2023010119261719100_R41 doi: 10.1016/S0165-2478(03)00151-2 – ident: 2023010119261719100_R54 doi: 10.4049/jimmunol.170.12.6355 – ident: 2023010119261719100_R19 doi: 10.1001/archsurg.1991.01410250080013 |
SSID | ssj0006024 |
Score | 2.1380029 |
Snippet | Fms-like tyrosine kinase-3 ligand (Flt3L) is a hemopoietic cytokine that stimulates the production of dendritic cells. This study evaluated the ability of... Abstract Fms-like tyrosine kinase-3 ligand (Flt3L) is a hemopoietic cytokine that stimulates the production of dendritic cells. This study evaluated the... |
SourceID | proquest crossref pubmed highwire |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 404 |
SubjectTerms | Adoptive Transfer Animals Burns - complications Cell Count Dendritic Cells - cytology Dendritic Cells - immunology Flow Cytometry fms-Like Tyrosine Kinase 3 Humans Ligands Mice Proto-Oncogene Proteins - metabolism Pseudomonas aeruginosa Pseudomonas Infections - etiology Pseudomonas Infections - prevention & control Receptor Protein-Tyrosine Kinases - metabolism Spleen - cytology Wound Infection - etiology Wound Infection - prevention & control |
Title | Enhancement of Dendritic Cell Production by Fms-Like Tyrosine Kinase-3 Ligand Increases the Resistance of Mice to a Burn Wound Infection |
URI | http://www.jimmunol.org/cgi/content/abstract/174/1/404 https://www.ncbi.nlm.nih.gov/pubmed/15611264 https://search.proquest.com/docview/17757136 https://search.proquest.com/docview/67332745 |
Volume | 174 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LjtMwFLXKIBAbBMOrw8sLWEUpeTtdIlQYIYZVR3QXOY4zEyZNRpNEVecL-A9-lHvjOEkHKgGbqHIiJ805uT6274OQN6llycR2UlOCnjdB34ZmHIYeCLnUDwUQKHUwGvnka3B86n1e-avJ5OfIa6mp45m4_mNcyf-gCm2AK0bJ_gOyfafQAL8BXzgCwnD8K4wXxTmCpvfzwYQkbeUCA5fj0fUqUblhUWOm68rMswtp1FsYGFFbXmQFDGGma-TZmcrBhAqywpwP6HYoK5SW-N3jFjzYE5Sp3AAQCmODxZh6R65irHCHWDOVjgLjT1Sep7ftbpo1WntYljm6hWAJ424NF4ZOsR1FRzSts8E3mZ03fIcbaqV9cZXLwWf5S9Z5EMjibJvJnQUNf7SgMQQY2ExV6eiNtKrls8NGZXI9Vb745lAAzZhJ9Xv3N9Fxa2bPblwMcF6uW3LANBaDqbxhWOydFfWpW-S2A9YMzein1eBHFFiOp1PS41OryCy8_bvfb95WgVLd7QohnZx6_0SnFTzLB-R-hyF9r2j3kExkcUjuqNql20Ny96TzynhEfox4SMuU9jykyEM68JDGW6p5SDUPqeYhVTykPQ8p8JAOPMSukYe0LimnyEPa8pD2PHxMTj8ulh-Oza7ChylA99emmAvOhIBJv-ACrAazEzvh0nU4c9NYOBaXQRyD4uaYhi-UzEnCIGBp7LrMAdvjPiEHRVnIZ4QGODWxQI0nCfNiGcx9Jn1fJHwu5BwMzpQY-nVHlyqRSwQTYMQp0jhFgFNkY9uUvNaIRNWa5zkgYUebzWZ8hQYqAouM75MXsmwq6IT5zHaD_VcEzHUd5vlT8lQhPDxRR46jvWeek3vDR_OCHNRXjXwJuriOX7W8_AXA3bty |
link.rule.ids | 315,783,787,27936,27937 |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Enhancement+of+dendritic+cell+production+by+fms-like+tyrosine+kinase-3+ligand+increases+the+resistance+of+mice+to+a+burn+wound+infection&rft.jtitle=The+Journal+of+immunology+%281950%29&rft.au=Toliver-Kinsky%2C+Tracy+E&rft.au=Cui%2C+Weihua&rft.au=Murphey%2C+Erle+D&rft.au=Lin%2C+Chengyie&rft.date=2005-01-01&rft.issn=0022-1767&rft.volume=174&rft.issue=1&rft.spage=404&rft_id=info:doi/10.4049%2Fjimmunol.174.1.404&rft_id=info%3Apmid%2F15611264&rft.externalDocID=15611264 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1767&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1767&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1767&client=summon |